Showing results (21-30 of 146) with videos related to
Sort By:
Pageof 15
EJNMMI Research|January 5, 2012
PET kinetics of radiolabeled antidepressant, [N-methyl-11C]mirtazapine, in the human brainOle L Munk, Donald F SmithMetabolic Brain Disease|December 11, 2008
Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathyMichael Sørensen, Ole Lajord Munk, Susanne KeidingEuropean Journal of Nuclear Medicine and Molecular Imaging|May 10, 2011
The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinomaMichael Sørensen, Kim Frisch, Dirk Bender, et al.Metabolic Brain Disease|February 26, 2010
No oxygen delivery limitation in hepatic encephalopathyAlbert Gjedde, Susanne Keiding, Hendrik Vilstrup, et al.Scandinavian Journal of Gastroenterology|November 2, 2010
Age-dependency of galactose elimination capacity in healthy children and children with chronic liver diseaseAksel Lange, Henning Grønbæk, Hendrik Vilstrup, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Determinants of [13N]ammonia kinetics in hepatic PET experiments: a minimal recirculatory modelMichael Weiss, Klaus Roelsgaard, Dirk Bender, et al.Scandinavian Journal of Gastroenterology|May 1, 2009
Hepatic ethanol elimination kinetics in patients with cirrhosisGitte Dam, Michael Sørensen, Ole Lajord Munk, et al.Acta Oncologica (Stockholm, Sweden)|August 26, 2017
Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificityMorten Busk, Ole L Munk, Steen S Jakobsen, et al.Metabolic Brain Disease|March 11, 2010
Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in bloodSusanne Keiding, Michael Sørensen, Ole Lajord Munk, et al.EJNMMI Research|March 7, 2022
Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patientsAndré H Dias, Allan K Hansen, Ole L Munk, et al.Pageof 15